MENU
FTH
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Faeth Therapeutics (FTH) Earnings Date & Reports
Faeth Therapeutics Inc is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways... Show more
A.I. Advisor
published Earnings
FTH is expected to report earnings to fall 4.15% to -75 cents per share on April 01
Q4'26
Est.
$-0.76
Q3'26
Missed
by $0.13
Q2'26
Beat
by $1.32
The last earnings report on November 03 showed earnings per share of -79 cents, missing the estimate of -66 cents. With 575.77K shares outstanding, the current market capitalization sits at 569.78M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Related Blogs
Interesting Articles
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Industry
N/A
Address
701 Tillery Street No. 12, No.1010
Phone
+1 240 243-8000
Employees
29
Web
https://www.faeththerapeutics.com